The Correlation of Lab Data, Hormone Peptides, Quality of Life, and Different Traditional Chinese Medicine Syndrome Groups in Type 2 Diabetes Patients

10.4103/2225-4110.110409

Ching-Min Luo；You-Lung Song；Lin-Huang Huang；Chia-Yu Liu；I-Ju Chen；Chung-Hua Hsu

Qi deficiency ； Quality of life ； Traditional Chinese medicine ； Type 2 diabetes

Journal of Traditional and Complementary Medicine

3卷2期（2013 / 04 / 01）

126 - 133

英文

The aim of this study is to explore the correlation of laboratory data, hormone peptides, and quality of life with different traditional Chinese medicine (TCM) syndrome groups in type 2 diabetes patients. Of 513 registered patients, 179 subjects aged between 20 and 65 years and having type 2 diabetes mellitus (T2DM) for more than 1 year were enrolled in the study. All the participants were asked to fill out a questionnaire on diabetic TCM syndrome groups, which was designed by professional TCM doctors, and two questionnaires on the quality of life (QOL), WHOQOL-BREF Taiwan version and Medical Outcomes Study (MOS) Short Form-12 (SF-12). The biochemical characteristics and hormone peptide levels were collected at the same time. The patients in any one of the six TCM syndrome groups had the trend to have worse QOL. Especially, patients with qi deficiency had worse life quality on every aspect compared to those without qi deficiency and were fatter than others. We also found that the subjects who had qi deficiency, qi stagnation, and yin deficiency at the same time had worsened condition. We consider that patients with qi deficiency may also be at a higher risk of developing other complications. They need more advanced health care than others. This self-reported questionnaire will be a reference for health care workers screening those T2DM patients who have a higher possibility of developing other complications. Especially in remote areas, where there is a lack of medical resources, an easy-to-use tool such as the one in the present study for detecting and evaluating disease conditions is needed.

1. Chien, TJ,Song, YL,Lin, CP,Hsu, CH(2011).The correlation of Traditional Chinese Medicine Deficiency Syndromes, cancer related fatigue, and quality of life in breast cancer patients.J Tradit Complement Med,2,204-210.
   連結：
2. Hsu, CH,Lee, CJ,Chien, TJ,Lin, CP,Chen, CH,Yuen, MJ(2011).The relationship between qi deficiency, cancer‑related fatigue and quality of life in cancer patients.J Tradit Complement Med,2,129-135.
   連結：
3. Song, YL,Lien, CY,Chiu, JP,Luo, CM,Liu, CY,Chen, IJ(2011).Relationship between obesity‑related hormone peptides and quality of life in obese women among different Traditional Chinese Medicine Syndrome Groups.J Tradit Complement Med,2,61-66.
   連結：
4. 10 facts about diabetes. Available from: http://www.who.int/features/factfiles/diabetes/en/. [Last accessed on 2011].
5. Agewall, S,Henareh, L(2008).Quality of life and insulin resistance in patients with coronary heart disease.Coron Artery Dis,19,289-292.
6. Agin, A,Jeandidier, N,Gasser, F,Grucker, D,Sapin, R(2006).Use of insulin immunoassays in clinical studies involving rapid‑acting insulin analogues: Bi‑insulin IRMA preliminary assessment.Clin Chem Lab Med,44,1379-1382.
7. Bergman, RN,Ader, M(2000).Free fatty acids and pathogenesis of type 2 diabetes mellitus.Trends Endocrinol Metab,11,351-356.
8. Berle, CA,Cobbin, D,Smith, N,Zaslawski, C(2010).A novel approach to evaluate Traditional Chinese Medicine treatment outcomes using pattern identification.J Alternat Complement Med,16,357-367.
9. Chan, JC,Malik, V,Jia, W,Kadowaki, T,Yajnik, CS,Yoon, KH(2009).Diabetes in Asia: Epidemiology, risk factors, and pathophysiology.JAMA,301,2129-2140.
10. Dey, L,Attele, AS,Yuan, CS(2002).Alternative therapies for type 2 diabetes.Alternat Med Rev,7,45-58.
11. Han, X,Abendschein, DR,Kelley, JG,Gross, RW(2000).Diabetes‑induced changes in specific lipid molecular species in rat myocardium.Biochem J,352(Pt 1),79-89.
12. Hsu, CH,Tsai, TH,Kao, YH,Hwang, KC,Tseng, TY,Chou, P(2008).Effect of green tea extract on obese women: A randomized, double‑blind, placebo‑controlled clinical trial.Clin Nutr,27,363-370.
13. Liao, WL,Chen, CC,Chang, CT,Wu, JY,Chen, CH,Huang, YC(2012).Gene polymorphisms of adiponectin and leptin receptor are associated with early onset of type 2 diabetes mellitus in the Taiwanese population.Int J Obes,36,790-796.
14. Lu, A,Jiang, M,Zhang, C,Chan, K(2012).An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis.J Ethnopharmacol,141,549-556.
15. Maggie, B,Covington, M(2001).Traditional Chinese medicine in the treatment of diabetes.Diabetes Spectrum,14,154-159.
16. Matthews, DR,Hosker, JP,Rudenski, AS,Naylor, BA,Treacher, DF,Turner, RC(1985).Homeostasis model assessment: Insulin resistance and beta‑cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia,28,415-419.
17. Pan, MZ,Li, L,Fan, H(2006).Relationship between quality of life and TCM syndrome types in patients with diabetes mellitus.Zhongguo Zhong Xi Yi Jie He Za Zhi,26,702-705.
18. Perassolo, MS,Almeida, JC,Prá, RL,Mello, VD,Maia, AL,Moulin, CC(2003).Fatty acid composition of serum lipid fractions in type 2 diabetic patients with microalbuminuria.Diabetes Care,26,613-618.
19. Schlotz, W,Ambery, P,Syddall, HE,Crozier, SR,Sayer, AA,Cooper, C(2007).Specific associations of insulin resistance with impaired health‑related quality of life in the Hertfordshire Cohort study.Qual Life Res,16,429-436.
20. Starr, JI,Mako, ME,Juhn, D,Rubenstein, AH(1978).Measurement of serum proinsulin‑like material: Cross‑reactivity of porcine and human proinsulin in the insulin radioimmunoassay.J Lab Clin Med,91,683-692.
21. Ware, J, Jr.,Kosinski, M,Keller, SD(1996).A12‑Item Short‑Form Health Survey: Construction of scales and preliminary tests of reliability and validity.Med Care,34,220-233.
22. Ware, JE,Kosinski, M,Keller, SD(1998).SF‑12: How to score the SF‑12 Physical and Mental Health Summary Scales.Boston, Mass:Quality Metric Inc..
23. Wild, S,Roglic, G,Green, A,Sicree, R,King, H(2004).Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030.Diabetes Care,27,1047-1053.
24. Xie, W,Zhao, Y,Zhang, Y(2011).Traditional chinese medicines in treatment of patients with type 2 diabetes mellitus.Evid‑Based Complement Alternat Med,2011,726723.
25. Xie, YQ,Wang, H,Wu, YP,Yin, DH,Wang, ZS,Huang, YH(2011).Association of APOE polymorphisms and insulin resistance with TCM syndromes in type 2 diabetes patients with macroangiopathy.Mol Med Rep,4,1219-1223.
26. Yang, W,Lu, J,Weng, J,Jia, W,Ji, L,Xiao, J(2010).Prevalence of diabetes among men and women in China.N Engl J Med,362,1090-1101.
27. Yao, G,Chung, CW,Yu, CF,Wang, JD(2002).Development and verification of validity and reliability of the WHOQOL‑BREF Taiwan version.J Formos Med Assoc,101,342-351.
28. Zhi, XY(2009).Traditional Chinese medicine diagnosis and treatment of type 2 diabetes in Tianjin urban population.Zhong Xi Yi Jie He Xue Bao,7,823-826.

1. Li-Wen Huang,I-Ju Chen,Chung-Hua Hsu(2016).Influence of traditional Chinese medicine syndrome groups on quality of life in women with metabolic syndrome.Journal of Traditional and Complementary Medicine,6(4),404-408.